Psoriatic patients with chronic viral hepatitis do not have an increased risk of liver cirrhosis despite long-term methotrexate use: Real-world data from a nationwide cohort study in Taiwan
Journal of the American Academy of Dermatology May 14, 2018
Tang KT, et al. - Experts intended to analyze the impact of long-term methotrexate (MTX) use on the risk of chronic viral hepatitis-related cirrhosis among psoriatic patients in Taiwan. They selected psoriatic patients with chronic hepatitis B (CHB) (370 MTX users and 2047 MTX non-users) and psoriatic patients with chronic hepatitis C (CHC) (174 MTX users and 953 MTX non-users) from January 1, 2000 to December 31, 2010. Yielded data demonstrated that long-term MTX use was possibly not related to an increased risk of liver cirrhosis among psoriatic patients with chronic viral hepatitis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries